Immunosuppressive strategies and management

作     者：Shi-hui PAN (Center for Liver Diseases and Transplantation,Cedars-Sinai Medical Center,Los Angeles CA 90048,USA ) 

作者机构：Centerfor Liver Diseases and TransplantationCedars-Sinai Medwd Center 美国 

出 版 物：《中国新药与临床杂志》 (Chinese Journal of New Drugs and Clinical Remedies)

年 卷 期：2008年第27卷第12期

页      面：942-943页

核心收录：

学科分类：1001[医学-基础医学(可授医学、理学学位)] 100102[医学-免疫学] 10[医学] 

主　　题：Immunosuppressive strategies and management 

摘      要：Advances in immunosuppressive therapy have significantly improved short-term allograft and patient ***,chronic allograft failure,antibody mediated rejection,recurrent diseases and immunosuppressive drug associated adverse effects remain serious barriers to long-term survival and quality of *** immunosuppressive agents and protocols are being evaluated to combat these ***, clinicians must work to manage post-transplant complications and avoid complex medication regimens,which will potentiate drug interactions and non-compliance.